TMCnet News
Great Success for the First Edition of "French Life Sciences Days"PARIS --(Business Wire)-- France Biotech, (www.france-biotech.org), an association of entrepreneurs in the life sciences industry, today announced the high level of interest in the first edition of "French Life Sciences Days" on June 25th and 26th in New York and is pleased to announce the event renewal next year on June 17th and 18th in New York. This brand new initiative allowed 19 Life Sciences companies, recently listed or more mature, with a market capitalization from Euro 25 to 477 million, developing Biotech and Medtech breakthrough technologies with advanced clinical results or sales. Their CEOs have displayed their business plans to 50 American non-specialized and specialized financial investors.
Our firms' investment opportunities have attracted prestigious names of
Finance from Boston, New York and Philadelphia. These investors showed a
tremendous interest in the 19 inovative companies during 70 one-to-one
meetings (about 4 meetings per company). "The Life Sciences Days are a major element in promoting and reinforcing the whole innovative SMEs funding scene, from startup to more mature companies. Our goal has been achieved: French innovation in the healthcare field has been recognized in the United States and the investors are convinced that world future champions are among us! The French financial players confirm Euronext's leading position. This event's success calls for further ones and we will renew this event on June 17th and 18th 2015 in New York and already plan the same initiative in Asia. I particularly thank our sponsors, Bryan Garnier & Co, Société Générale, Invest Securities, Deloitte (News - Alert), Mazars and NewCap who have been key to this success!", Pierre-Olivier Goineau, the president of France Biotech, said.
About the "French Life Sciences Days"
About France Biotech
|